Skip to content

HELLO PHARMA

Active Private limited companyfounded 2018active for 8 yearsRue de Spa 15, 4020 LiègeKBO/BCE: BE 0689.779.668

Lifetime

8 annual accounts with figures on one time axis
peak of €175,670 in 2025
€175,670▲ 168%
peak of €101,939 in 2025
€101,939▲ 354%
peak of €215,008 in 2025
€215,008▲ 21.9%
€87,006▲ 20.1%
Board2 names since 2018
2 directors and 1 other
Documentsfilings and deeds
24-08-202624 days late
2025micro format
Gross margin from €65,516 to €175,670Result from €22,429 to €101,939Dividend €63,290Equity from €176,359 to €215,008Debts from €72,426 to €87,006Cash from €96,850 to €167,143

Key points

from the 2025 annual accounts

Equity

€215,008 ▲ 21.9%
176,3592024+101,939Profit-63,290Dividend215,0082025

HELLO PHARMA paid out €63,290 in dividends. That is 62% of the 2025 profit.

Result

€101,939 ▲ 354%
€22,4002024€102,0002025

The result rose in 2025 from €22,429 to €101,939.

Turnover

≈ €430,000 estimated

The micro format states no turnover.

Filings

8 annual accounts 6 late
AprilJune31 JulyOctober20202025

The 2020 accounts came in latest, 30 days after the end of the period.

Position in the sector

€101,939

Higher net result than 80% of companies in research and development. The sector median is €23,595, over 670 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as HELLO PHARMA has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for HELLO PHARMA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Director
  • 185 sharesdeed of 07-02-2018
  • 1 sharedeed of 07-02-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0689779668
(director) and (director) change roles Discharge granted to (mandate holder) · Discharge granted to (mandate holder) · General meeting of 15-12-2021 · Gazette deed
appointed as manager General meeting of 21-09-2018 · Gazette deed
First establishment Rue de Spa 15, Liège
All 18 events

Comparable companies

same main activity, similar in size and age
Company
HELLO PHARMA Liège €302,014 €175,670 71.2% -
MCLC Zedelgem €351,344 €131,227 32.8% -
Artelys Belgium Brussels €269,967 €257,451 62.2% 2
Cornet & Renard Lubbeek €258,967 €114,835 60.1% -
Transversality Evere €293,152 €96,425 87.0% -
LOVAT FRASER CONSULTING Charleroi €366,634 €282,675 75.9% -
FLEXide Energy Bastogne €228,061 €152,349 32.2% -

These companies have the same main activity as HELLO PHARMA: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €228,000 and €367,000, founded between 2016 and 2018.

Official details

Source: KBO
Status
Active since 05-02-2018Normal situation
Activity
Other research and development on natural sciencesNACE 72109
Establishment unit
2.273.283.0904020 Liège, since 12-03-2018
Financial year end
31 December
Peppol
Reachable since 25-11-2025
Company details

Annual accounts 2025

€302,014▲ 21.4%
Filing
Filed on 24-08-2026
Financials

Insights on HELLO PHARMA

HELLO PHARMA files the micro format. That format states no turnover. The gross margin rose from €36,438 in 2018 to €175,670 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about HELLO PHARMA

What is the company number of HELLO PHARMA?
The company number of HELLO PHARMA is 0689.779.668. The VAT number is the same number with BE in front: BE 0689.779.668.
Where is HELLO PHARMA based?
The registered office is at Rue de Spa 15, 4020 Liège.Company details
What does HELLO PHARMA do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of HELLO PHARMA?
HELLO PHARMA is a private limited company (BV).
When was HELLO PHARMA founded?
HELLO PHARMA was founded on 05-02-2018.
Is HELLO PHARMA still active?
Yes, HELLO PHARMA is an active enterprise in the KBO register.
What is the turnover of HELLO PHARMA?
The turnover in financial year 2025 is about €430,000. This figure is estimated from the gross margin of €175,670 and 2,452 comparable companies of the same size. It probably lies between €290,000 and €680,000. It is a rough estimate.Financials
Is HELLO PHARMA profitable?
In financial year 2025, HELLO PHARMA made a profit of €101,939.
Where can I find the annual accounts of HELLO PHARMA?
HELLO PHARMA filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of HELLO PHARMA due?
HELLO PHARMA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.